1Shering SG, Zbar AP. Thyroid disorders and breast cancer [J]. Eur J Cancer Prev, 1996, 5(6): 504-506.
2Fante R, Roncucci L, Di Gregorio C. Frequency and clin- ical features of muhiple tumors of the large bowel in gene- ral population and in patients with hereditary colorectal carcinoma[J]. Cancer, 1996, 77(10): 2013-2021.
3Giani C, Fierabracci P. Relationship between breast can-cer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy [J]. J Clin Endocrinol Metab, 1996, 81 (3): 990-994.
7Banu SK, Govindarajulu P, Aruldhas MM. Testosterone and estradiol upregulate and rogen and estrogen receptors in immature and adult rat thyroid glands in vivo [J]. Steroids, 2002, 67(13): 1007-1014.
8Chen AY, Levy L, Goepfcrt H, et al. The development of breast carcinoma in women with thyroid carcinoma [J]. Cancer, 2001, 92(2): 225-231.
9Smyth PP, Smith DF, McDermott EW, etal. A direct rela- tionship between thyroid enlargement and breast cancer[J] J Clin Endocfinol Metab, 1996, 81(3): 937-941.
3Lewy-Trenda I. Estrogen and progesterone receptors in neoplastic and non-neoplastic thyroid lesions [ J ]. Pol J Pathol, 2002,53(2): 67-72.
4白耀.甲状腺疾病学[M](第1版)[M].北京:北京科技文献出版社,2003.349.
5Pines J. Cyclins and cyclin-dependent kinase: a biochemical view [ J ]. Biochem J, 1995,308 ( 6 ): 697 -711.
6Quelle DE, Ashmun RA, Shurtleff SA, et al. Overexpression of mouse D-type cyclin D1 accelerates G1 phase in rodent fibroblasts [J]. Genes Dev, 2000,26(4): 807-812.
7Wang S, Lioyd RV, Hutzler MJ, et al. The role of cell cycle regulatory protein, cyclin D1 in the progression of thyroid cancer [J]. Mod Pathol,2000 ,13( 8 ) : 882-887.
8Kodama T, Fujimoto Y, Obara T, et al. Justification of conservative surgical treatment of childhood thyroid cancer: report of eleven cases and analysis of Japanese literature [J]. Jpn J Cancer Res,1986,77(8): 799-807.
9Barbareschi M, Pelosio P, Caffo O, et al. Cyclin D1-gene amplification and expression in breast carcinoma: relation with clinicopathologic characteristics and with retinoblastoma gene product,P53 and P21WAF1 immunohistochemical expression [ J ]. Int J Cancer,1997,74(2): 171-174.
10Sica V, Nola F, Contieri E, et al. Estradiol and progesterone receptors in malignant gastrointestinal tumors [ J ]. Cancer Res,1984,44(10): 4670-4674.
4Fante R,Roncucci L,Di Gregorio C,et al.Frequency and clinical features of multiple tumors of the large bowel in general population and in patients with hereditary colorectal carcinoma[J].Cancer,1996,77(10):2013-2021.
5Warren S,Gates O.Multiple primary malignant tumors,a survey of the literature and a statistical study[J].Am J Cancer,1932,16(2):1358-1363.
6Beatson G.On the treatment of inoperable cases of carcinoma of the mamma:suggestions for a new method of treatment,with illustrative cases[J].Lacent,1896,2:104-110.
7Shering SG,Zbar AP,Motiarym,et al Thyroid disorders and breast cancer[J].Eur J Cancer Prev,1996,5(6):504-506.
8Smyth PP,Smith DF,Mc Dermott EW,et al.A direct relationship between thyroid enlargement and breast cancer[J].J Clin Endocrinol Metab,1996,81(3):937-941.
9Yoo HJ,Sepkovic DW,Bradlow HL.Estrogen metabolism as a risk factor for head and neck cancer[J].Otolaryngol Head Neck Surg,2001,124(3):241-247.
10Kansakar E,Chang YJ,Mehrabi M,et al.Expression of estrogen receptor,progesterone receptor,and vascular endothelial growth factor-A in thyroid cancer[J].Am Surg,2009,75(9):785-789.
